AlphaFold predicted structure
CEP164 · Q9UPV0

Mean pLDDT
61.7/ 100
Low
1,460 residues
Confidence breakdown
- Very high(≥ 90)28%
- Confident(70–90)18%
- Low(50–70)6%
- Very low(< 50)48%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
centrosomal protein 164
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Cystic kidney disease
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalOphthalmological ciliopathies
BIALLELIC, autosomal or pseudoautosomalRare multisystem ciliopathy disorders
BIALLELIC, autosomal or pseudoautosomalRenal ciliopathies
BIALLELIC, autosomal or pseudoautosomalRespiratory ciliopathies including non-CF bronchiectasis
BIALLELIC, autosomal or pseudoautosomalRetinal disorders
BIALLELIC, autosomal or pseudoautosomalTubulointerstitial kidney disease
BIALLELIC, autosomal or pseudoautosomal+7 more panels — install the extension to see the full list inline on any page.
Senior-Loken syndrome
nephronophthisis 15
ciliopathy
Retinal dystrophy
nephronophthisis
bronchiectasis
CEP164-related ciliopathy
familial lipoprotein lipase deficiency
inborn disorder of amino acid metabolism
hereditary disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Centrosomal protein of 164 kDa
Plays a role in microtubule organization and/or maintenance for the formation of primary cilia (PC), a microtubule-based structure that protrudes from the surface of epithelial cells. Plays a critical role in G2/M checkpoint and nuclear divisions. A key player in the DNA damage-activated ATR/ATM signaling cascade since it is required for the proper phosphorylation of H2AX, RPA, CHEK2 and CHEK1. Plays a critical role in chromosome segregation, acting as a mediator required for the maintenance of genomic stability through modulation of MDC1, RPA and CHEK1
Curated MONDO disease pages that list CEP164 among their top associated genes.
CEP164 · Q9UPV0

Mean pLDDT
61.7/ 100
Low
1,460 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0